The U.S. Food and Drug Administration on Friday morning authorized the Pfizer-BioNTech and Moderna COVID-19 boosters for use in all adults, The Washington Post reports. The authorization is a "one-size-fits-all strategy" aimed at both hardening Americans' defenses against the virus" and "widening the booster campaign" to contend with a recent increase in cases, per the Post and The Wall Street Journal.
Subscribe to The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.
Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
Create an account with the same email registered to your subscription to unlock access.
-
Do youth curfews work?Today's big question Banning unaccompanied children from towns and cities is popular with some voters but is contentious politically
-
'Sleaze baack!'Today's Newspapers A roundup of the headlines from the US front pages
-
Quiz of The Week: 20 - 26 AprilPuzzles and Quizzes Have you been paying attention to The Week's news?
-
Texas dairy worker gets bird flu from infected cowSpeed Read The virus has been spreading among cattle in Texas, Kansas, Michigan and New Mexico
-
Dengue hits the Americas hard and earlySpeed Read Puerto Rico has declared an epidemic as dengue cases surge
-
Covid four years on: have we got over the pandemic?Today's Big Question Brits suffering from both lockdown nostalgia and collective trauma that refuses to go away
-
US bans final type of asbestosSpeed Read Exposure to asbestos causes about 40,000 deaths in the U.S. each year
-
The hollow classroomOpinion Remote school let kids down. It will take much more than extra tutoring for kids to recover.
-
Excess screen time is making children only see what is in front of themUnder the radar The future is looking blurry. And very nearsighted.
-
Covid-19: what to know about UK's new Juno and Pirola variantsin depth Rapidly spreading new JN.1 strain is 'yet another reminder that the pandemic is far from over'
-
Long-term respiratory illness is here to stayThe Explainer Covid is not the only disease with a long version
